Eureka Therapeutics Inc.
6 clinical trials · Sponsor
◉ Watch Eureka Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC (NCT04864054) | Eureka Therapeutics Inc. | 2022-03-11 |
| Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) (NCT04502082) | Eureka Therapeutics Inc. | 2021-04-14 |
| Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma (NCT03998033) | Eureka Therapeutics Inc. | 2019-05-30 |
| Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma (NCT03379493) | Eureka Therapeutics Inc. | 2018-04-04 |
| Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma (NCT03415399) | Eureka Therapeutics Inc. | 2017-09-09 |
Track Eureka Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.